+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Combination Drugs Development"

  • 2 Results (Page 1 of 1)
Loading Indicator

The Combination Drugs Development market is a subset of the Drug Discovery industry. It focuses on the development of drugs that combine two or more active ingredients to treat a single condition. This approach is often used to increase the efficacy of a drug, reduce side effects, or improve patient compliance. The process of developing combination drugs involves a range of activities, including preclinical and clinical research, regulatory approval, and manufacturing. The Combination Drugs Development market is highly competitive, with a number of large pharmaceutical companies and smaller biotechnology firms vying for market share. Companies in the market are investing heavily in research and development to create new combination drugs and improve existing ones. Notable companies in the Combination Drugs Development market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more